Algemeen Ziekenhuis Jan Portaels
- Address
- Gendarmeriestraat 65, 1800 Vilvoorde, Belgium
Algemeen Ziekenhuis Jan Portaels - Rheumatoid Arthritis Research Center
Algemeen Ziekenhuis Jan Portaels is actively engaged in advancing the treatment paradigms for patients with early rheumatoid arthritis. The center participates in innovative research focused on optimizing remission induction strategies and evaluating accelerated access to biologic therapies for patients with insufficient response to conventional treatment approaches.
- Early rheumatoid arthritis remission induction strategies
- Accelerated TNF blockade therapy optimization
- Long-term disease course evaluation and treatment outcomes
The center's research specifically investigates the COBRA-Slim treatment strategy combined with fast-track access to anti-TNF therapy (etanercept) for patients who demonstrate insufficient response to initial remission induction therapy. Through both randomized controlled trials and extended long-term observational follow-up studies, the research team evaluates disease burden reduction, treatment response stability, and safety profiles over multi-year periods, contributing valuable insights into personalized treatment algorithms for rheumatoid arthritis patients.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 307 other sites in Belgium
Therapeutic Area Benchmark — Belgium
Select a therapeutic area to compare against other sites in Belgium.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Belgium
Market Share
Country: Belgium
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Algemeen Ziekenhuis Jan Portaels
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Methotrexate and Glucocorticoid Regimen with Optional Etanercept in Early Rheumatoid Arthritis: A Randomized, Multicenter Trial | UZ Leuven | Phase III | Not Recruiting | May 2018 | Jul 2025 |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Etanercept | 1 | Unknown | 2018-05-15 | 2018-05-15 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.